Clinical implications of the metabolic syndrome

Diabetes and Vascular Disease Research

Volumn 4, Issue SUPPL. 3, 2007, Pages

  Ceska, Richard ^a  

^a General Teaching Hospital   (Czech Republic)

Author keywords

Cardiovascular risk; Dyslipidaemia; Metabolic syndrome; Obesity

Indexed keywords

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; DEVELOPING COUNTRY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; HUMAN; HYPERTENSION; INFLAMMATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE;

AGE DISTRIBUTION; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; HUMANS; HYPERTENSION; METABOLIC SYNDROME X; OBESITY; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 35548986970     PISSN: 14791641     EISSN: None     Source Type: Journal    
DOI: 10.3132/dvdr.2007.049     Document Type: Conference Paper

References (19)

1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9.
2. Mokdad AH, Serdula MK, Dietz WH et al. The continuing epidemic of obesity in the United States. JAMA 2000;284:1650-1.
3. The IDF consensus worldwide definition of the metabolic syndrome. Available from http://www.idf.org
4. Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937- 52.
5. Rana JS, Nieuwdorp M, Jukema JW, Kastelein JJ. Cardiovascular metabolic syndrome - an interplay of obesity, inflammation, diabetes and coronary heart disease. Diabetes Obes Metab 2007;9:218-32.
6. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-28.
7. Charles MA, Eschwege E, Thibult N et al. The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study. Diabetologia 1997;40:110-16.
8. Empana JP, Ducimetiere P, Charles MA, Jouven X. Sagittal abdominal diameter and risk of sudden death in asymptomatic middle-aged men. The Paris Prospective Study I. Circulation 2004;110:2781-5.
9. Isomaa B, Almgren P, Tuomi T et al. Cardiovascular morbidity and mor-tality associated with the metabolic syndrome. Diabetes Care 2001;24: 683-9.
10. Lakka H-M, Laaksonen DE, Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16.
11. Takeuchi H, Saitoh S, Takagi S et al. Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program Adult Treatment Panel III to Japanese men - the Tanno and Sobetsu Study. Hypertens Res 2005;28:203-08.
12. Hunt KJ, Resendez RG, Williams K et al. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004;110:1251-7.
13. Sniderman AD, Lamarche B, Tilley J et al. Hypertriglyceridemic hyperapoB in type 2 diabetes. Diabetes Care 2002;25:579-82.
14. Turner RC, Millns H, Neil HAW et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS 23). BMJ 1998;316:823-8.
15. UKPDS. UK Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Care 1997;20: 1683-7.
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 2001;285:2486-97.
17. Ryden L, Standi E, Bartnik M et al. on behalf of the Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. Eur Heart J 2007;28:88-136.
18. Lamarche B, Tchernof A, Moorjani S et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 1997;95:69-75.
19. Austin MA, Edwards KL. Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes. Curr Opin Lipidol 1996;7:167-71.